Evidence map›Paper›PMID 37371600›Full record

ArticleBiomedicines2023

Lung Transplantation for Pleuroparenchymal Fibroelastosis: A Single-Center Experience with Revision of Literature.

Eleonora Faccioli, Vincenzo Verzeletti, Chiara Giraudo, Marco Schiavon, Fiorella Calabrese, Monica Loy, Federico Rea, Andrea Dell'Amore

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Lung transplantation for interstitial lung disease.Breathe (Sheffield, England) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Eleonora FaccioliThoracic Surgery and Lung Transplant Unit, Department of Cardiac-Thoracic-Vascular Sciences and Public Health, University Hospital of Padua, 35128 Padua, Italy.
Vincenzo VerzelettiThoracic Surgery and Lung Transplant Unit, Department of Cardiac-Thoracic-Vascular Sciences and Public Health, University Hospital of Padua, 35128 Padua, Italy.ORCID 0000-0001-7239-1248
Chiara GiraudoRadiology Unit, Department of Medicine, University Hospital of Padua, 35128 Padua, Italy.ORCID 0000-0003-0924-5883
Marco SchiavonThoracic Surgery and Lung Transplant Unit, Department of Cardiac-Thoracic-Vascular Sciences and Public Health, University Hospital of Padua, 35128 Padua, Italy.
Fiorella CalabresePathology Unit, Department of Cardiac-Thoracic-Vascular Sciences and Public Health, University Hospital of Padua, 35128 Padua, Italy.
Monica LoyThoracic Surgery and Lung Transplant Unit, Department of Cardiac-Thoracic-Vascular Sciences and Public Health, University Hospital of Padua, 35128 Padua, Italy.
Federico ReaThoracic Surgery and Lung Transplant Unit, Department of Cardiac-Thoracic-Vascular Sciences and Public Health, University Hospital of Padua, 35128 Padua, Italy.
Andrea Dell'AmoreThoracic Surgery and Lung Transplant Unit, Department of Cardiac-Thoracic-Vascular Sciences and Public Health, University Hospital of Padua, 35128 Padua, Italy.
University of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pleuroparenchymal fibroelastosis (PPFE) is a rare condition characterized by fibrosis involving the pleura and the upper lobes which can be idiopathic or secondary to chemotherapy, transplantations and occupational exposure. For the end-stage form, lung transplantation (LT) is the treatment of choice. The aim of this study was to report our single-center experience for patients subjected to LT for PPFE and comparing it with the already published evidence on this topic. At our center, we have performed 6 bilateral LTs for patients with PPFE (3 males and 3 females) with a median age of 52 years. Median ICU and in-hospital length of stay were 8 and 30 days, respectively. To date, two patients are alive and four are dead, with a median overall survival of 10 months. In addition, after a formal search using the terms "pleuroparenchymal fibroelastosis AND lung transplantation", we collected 14 studies focused on outcomes after LT. LT for PPFE is technically challenging and its post-operative course could also be complicated. Current available data on LT outcomes are extremely poor and mostly limited to case reports. Further studies need to be published to improve knowledge of this disease and to achieve best outcomes for LT.

Indexed as

lung transplantationoutcomespleuroparenchymal fibroelastosis

Identifiers

PMID37371600
PMCPMC10295319
OpenAlexW4378085964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.